Skip to main content
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
433.00
+0.17 (0.04%)
Mar 9, 2026, 3:35 PM EDT - Market open

Madrigal Pharmaceuticals Revenue

In the year 2025, Madrigal Pharmaceuticals had annual revenue of $958.40M with 432.05% growth. Madrigal Pharmaceuticals had revenue of $321.08M in the quarter ending December 31, 2025, with 210.77% growth.

Revenue (ttm)
$958.40M
Revenue Growth
+432.05%
P/S Ratio
10.22
Revenue / Employee
$1,047,435
Employees
915
Market Cap
9.93B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025958.40M778.27M432.05%
Dec 31, 2024180.13M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jazz Pharmaceuticals 4.27B
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Bio-Techne 1.22B
Arrowhead Pharmaceuticals 1.09B
Axsome Therapeutics 638.50M
ImmunityBio 113.29M
Praxis Precision Medicines 7.46M
Revenue Rankings

MDGL News

More News